The University of Chicago Header Logo

Daniel Shevrin

Concepts (268)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Daniel Shevrin's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Daniel Shevrin has written about over time.
Hypercalcemia, 10 publications between 1984 and 1990, average publication date August 1987. Bone Neoplasms, 4 publications between 1988 and 2019, average publication date June 2003. Male, 46 publications between 1984 and 2024, average publication date July 2006. Prostatic Neoplasms, 28 publications between 1988 and 2024, average publication date September 2006. Fatigue, 5 publications between 2005 and 2011, average publication date July 2008. Antineoplastic Agents, 7 publications between 1986 and 2019, average publication date August 2008. Quality of Life, 9 publications between 2003 and 2022, average publication date March 2012. 5-alpha Reductase Inhibitors, 2 publications between 2013 and 2014, average publication date February 2014. Testosterone, 4 publications between 2010 and 2024, average publication date July 2014. Antineoplastic Combined Chemotherapy Protocols, 10 publications between 2000 and 2024, average publication date October 2014. Prostate-Specific Antigen, 8 publications between 2010 and 2024, average publication date April 2016. PTEN Phosphohydrolase, 1 publications between 2016 and 2016, average publication date June 2016. Receptors, Androgen, 2 publications between 2016 and 2017, average publication date March 2017. Neoplasms, Hormone-Dependent, 2 publications between 2017 and 2018, average publication date January 2018. Androgen Antagonists, 8 publications between 2010 and 2024, average publication date February 2018. Prostatic Neoplasms, Castration-Resistant, 9 publications between 2014 and 2024, average publication date March 2019. Androstenes, 2 publications between 2017 and 2024, average publication date May 2021. Poly(ADP-ribose) Polymerase Inhibitors, 2 publications between 2017 and 2024, average publication date May 2021. Phthalazines, 1 publications between 2024 and 2024, average publication date September 2024.

To see the data from this visualization as text, click here.
Shevrin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (268)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_